Counseling via analogy: Improving patient adherence in major depressive disorder

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 7, Issue 6, 2006, Pages 300-303

  Dunlop, Boadie W ^a   Dunlop, Anne L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; GLUCAGON; INSULIN; NORADRENALIN; SEROTONIN;

COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERTENSION; MAJOR DEPRESSION; NOTE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PSYCHOTHERAPY; RISK FACTOR; SUICIDAL BEHAVIOR; TREATMENT OUTCOME;

EID: 33748560795     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v07n0606     Document Type: Note

References (39)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105
2. National Institute of Mental Health. Suicide Facts and Statistics [monograph on the Internet]. Washington, DC: National Academy Press; 2004. Available at: http://www.nimh.nih.gov/suicideprevention/suifact.cfm. Accessed March 18, 2005
3. Judd LL, Paulus MP, Wells KB, et al. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996;153:1411-1417
4. Wells K, Stewart AL, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-919
5. Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA 2003;289:3135-3144
6. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000;62:463-471
7. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study. Arch Fam Med 1997;6:43-49
8. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-1825
9. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285-294
10. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996
11. Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med 2002;17:103-111
12. Souery D, Mendlewicz J. Compliance and therapeutic issues in resistant depression. Int Clin Psychopharmacol 1998;13:S13-S18
13. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003;13(suppl 5):S69-S75
14. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97-108
15. Fava M, Rosenbaum JF, McGrath PJ. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 1994;151:1372-1374
16. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990;51(suppl):39-47
17. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-225
18. Blumenthal SJ, Kupfer DJ, eds. Suicide Over the Life Cycle: Risk Factors, Assessment, and Treatment of Suicidal Patients. Washington, DC: American Psychiatric Association; 1990
19. Lin EHB, Katon WJ, VonKorff M, et al. Relapse of depression in primary care. Arch Fam Med 1998;7:443-449
20. NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry 1985;142:469-476
21. Angst J. Clinical course of affective disorders. In: Helgason T, Daly R, eds. Depressive Illness: Prediction of Course and Outcome. Berlin, Germany: Springer-Verlag; 1988:1-47
22. Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 2001;286:2947-2955
23. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998;280:1665-1672
24. Mechanic D. The epidemiology of illness behavior and its relationship to physical and psychological distress. In: Mechanic D, ed. Symptoms, Illness Behavior and Help Seeking. New York, NY: Prodist; 1982:1-24
25. Leaf PJ, Bruce ML, Tischler GL, et al. Factors affecting the utilization of specialty and general medical mental health services. Med Care 1988;26:9-26
26. Greenly J, Mechanic D. Social selection for those seeking help for psychological problems. J Health Soc Behav 1976;17:249-262
27. Mechanic D, Angel R, Davies L. Risk and selection processes between the general and the specialty mental health sectors. J Health Soc Behav 1991;32:49-64
28. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance abuse disorders. Arch Gen Psychiatry 2002;59:77-84
29. Fortney J, Rost K, Zhang M. A joint choice model of the decision to seek depression treatment and choice of provider sector. Med Care 1998;36:307-320
30. Blumenthal R, Endicott J. Barriers to seeking treatment for major depression. Depress Anxiety 1996;4:273-278
31. Van Voorhees BW, Cooper LA, Rost KM, et al. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med 2003;18:991-1000
32. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001;7:541-547
33. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-843
34. Jorm AF, Korten AE, Jacomb PA, et al. Helpfulness of interventions for mental disorders: beliefs of health professionals compared with the general public. Br J Psychiatry 1997;171:233-237
35. Vergouwen AC, Bakker A, Katon WJ, et al. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 2003;64:1415-1420
36. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change. New York, NY: Guilford Press; 2002
37. Fiore M, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Rockville, Md: US Dept Health and Human Services; 2000
38. Glover J, Greenlund KJ, Ayala C, et al. Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. Morb Mortal Wkly Rep 2005;54:7-9
39. Acton KJ, Burrows NR, Geiss LS, et al. Diabetes prevalence among the overall population - United States, 1994-2002. Morb Mortal Wkly Rep 2003;52:702-704